Skip to main navigation Skip to main content Skip to footer For Medicare For Providers For Brokers For Employers Español For Individuals & Families: For Individuals & Families Medical Dental Other Supplemental Explore coverage through work How to Buy Health Insurance Types of Dental Insurance Open Enrollment vs. Special Enrollment See all topics Shop for Medicare plans Member Guide Find a Doctor Log in to myCigna
Home Knowledge Center Wellness Library Juvenile Idiopathic Arthritis: Inflammatory Eye Disease

Juvenile Idiopathic Arthritis: Inflammatory Eye Disease

Topic Overview

Inflammatory eye disease (uveitis) can develop as a complication in children who have juvenile idiopathic arthritis (JIA). Children and adults who have JIA can develop cataracts, glaucoma, corneal degeneration (band keratopathy), or vision loss.

The incidence of eye disease is 2 to 34 out of 100 children who have JIA. footnote 1It is most common in oligoarticular and RF-negative polyarticular forms of the disease. Eye disease associated with JIA often has no symptoms, although blurred vision may be an early sign. To prevent eye problems from progressing to the point that vision loss occurs, regular eye examinations by an ophthalmologist are very important for children who have JIA.

Eye disease develops in about 30 out of 100 children who have oligoarticular JIA, particularly children who have a positive antinuclear antibody (ANA) test result.footnote 2

Early detection and treatment of inflammatory eye disease gives a child the best chance of a good outcome. Discuss the appropriate examination schedule with your doctor. Your doctor will consider many things when deciding how often to recommend an eye examination. He or she will think about the type of arthritis, the age of the child when the disease began, how long the child has had JIA, and whether or not eye disease is present. Over time, the child may need fewer examinations each year. But he or she should continue to have regular eye examinations.

Long-term outlook (prognosis)

Most children with inflammatory eye disease maintain good vision. Some do not.

If eye disease occurs, most children are treated with corticosteroids and prescription eyedrops. More severe eye disease, or eye disease that does not respond to these treatments, may be treated with other medicines such as azathioprine or methotrexate.footnote 2

The outlook for inflammatory eye disease has improved. Early and aggressive treatment of uveitis has reduced the complications of eye disease in JIA. Before treatment with methotrexate and TNF inhibitors became common, only about 1 out of 4 children had a good long-term vision outcome. Today, because of early treatment and better medicines, children with eye inflammation have a better chance of having a good vision outcome with less treatment.footnote 1

References

References

Citations

  1. Cassidy J, et al. (2006). Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics, 117(5): 1843–1845.
  2. Hsu JJ, et al. (2013). Treatment of juvenile idiopathic arthritis. In GS Firestein et al., eds., Kelley's Textbook of Rheumatology, 9th ed., vol. 2, pp. 1752–1770. Philadelphia: Saunders.

This information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.

© 1995-2022 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.

Related Links

Juvenile Idiopathic Arthritis

<cipublic-spinner variant="large"><span>Loading…</span></cipublic-spinner>

Page Footer

I want to...

Get an ID card File a claim View my claims and EOBs Check coverage under my plan See prescription drug list Find an in-network doctor, dentist, or facility Find a form Find 1095-B tax form information View the Cigna Glossary Contact Cigna

Audiences

Individuals and Families Medicare Employers Brokers Providers

Secure Member Sites

myCigna member portal Health Care Provider portal Cigna for Employers Client Resource Portal Cigna for Brokers

Cigna Company Information

About Cigna Company Profile Careers Newsroom Investors Suppliers Third Party Administrators International Evernorth

 Cigna. All rights reserved.

Privacy Legal Product Disclosures Cigna Company Names Customer Rights Accessibility Non-Discrimination Notice [PDF] Language Assistance [PDF] Report Fraud Sitemap

Disclaimer

Individual and family medical and dental insurance plans are insured by Cigna Health and Life Insurance Company (CHLIC), Cigna HealthCare of Arizona, Inc., Cigna HealthCare of Illinois, Inc., and Cigna HealthCare of North Carolina, Inc. Group health insurance and health benefit plans are insured or administered by CHLIC, Connecticut General Life Insurance Company (CGLIC), or their affiliates (see a listing of the legal entities  that insure or administer group HMO, dental HMO, and other products or services in your state). Accidental Injury, Critical Illness, and Hospital Care plans or insurance policies are distributed exclusively by or through operating subsidiaries of Cigna Corporation, are administered by Cigna Health and Life Insurance Company, and are insured by either (i) Cigna Health and Life Insurance Company (Bloomfield, CT); (ii) Life Insurance Company of North America (“LINA”) (Philadelphia, PA); or (iii) New York Life Group Insurance Company of NY (“NYLGICNY”) (New York, NY), formerly known as Cigna Life Insurance Company of New York. The Cigna name, logo, and other Cigna marks are owned by Cigna Intellectual Property, Inc. LINA and NYLGICNY are not affiliates of Cigna.

All insurance policies and group benefit plans contain exclusions and limitations. For availability, costs and complete details of coverage, contact a licensed agent or Cigna sales representative. This website is not intended for residents of New Mexico.

Selecting these links will take you away from Cigna.com to another website, which may be a non-Cigna website. Cigna may not control the content or links of non-Cigna websites. Details